As the new year approaches, we look back with gratitude for yet another year packed with scientific breakthroughs in children’s health. Continuing a remarkable run for personalized gene therapies, 2018 marked the European Commission’s approval of two gene therapies pioneered at Children’s Hospital of Philadelphia and the University of Pennsylvania, as patients in the European Union (EU) may now be treated with chimeric antigen receptor (CAR)-T cell therapy for aggressive forms of leukemia, and the very first gene therapy developed for inherited blindness.
Tag Archive: Melvin Bates
As part of a three-part Q&A series on Cornerstone, we’re learning more about the newest scholars of the Children’s Hospital of Philadelphia Postdoctoral Fellowship for Academic Diversity, a program that aims to expand our community of researchers from unique backgrounds and academic experiences. Central to our breakthroughs at CHOP, diversity allows our investigators to collaborate and confront pediatric problems from a variety of perspectives. In this series, we let each of our fellows tell their own stories, touching on everything from what diversity in research means to them to the exciting projects they have underway.